Press-release for stocks related to pharma for alpmf

| -4.86% | O: 0.41% H: 0.0% C: 0.0%
CSLLY | $90.71 3.3% 35K

| -3.75% | O: -4.92% H: 3.76% C: 3.44%
GLAXF | News | $19.54 -14.18% 2.6K

| -8.99% | O: -3.4% H: 1.49% C: 1.49%
AZNCF | News | $140.3 -4.19% 1.5K

| 7.0% | O: 1.55% H: 0.82% C: 0.16%
ALPMY | News | $9.49 -1.11% 480K

| -10.64% | O: -1.41% H: 5.06% C: 4.01%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| -4.4% | O: -0.6% H: 0.19% C: 0.09%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -10.93% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -2.08% | O: 0.57% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 6.54% | O: 1.08% H: 0.82% C: 0.67%
pharma vaccine astrazeneca research key market

Vivtex Enters Research Collaboration with Astellas Pharma
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
ALPMF | News | $9.5 43.47% 1.2K

| -21.08% | O: 0.27% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K

| -17.98% | O: -0.11% H: 0.37% C: -0.15%
pharma research collaboration

Outcome Capital Announces Acquisition of Propella Therapeutics, Portfolio Company of Peterson Companies, by Astellas Pharma
Published: 2024-01-04 (Crawled : 23:00) - biospace.com/
ALPMF | News | $9.5 43.47% 1.2K

| -20.52% | O: -0.02% H: 2.93% C: 2.93%
ALPMY | News | $9.49 -1.11% 480K

| -19.3% | O: 2.89% H: 0.58% C: -0.33%
pharma company acquisition

Pompe Disease Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Leading Companies - Asklepios Biopharmaceutical, Inc., Astellas Pharma Inc., Amicus Therapeutics, Sanofi, Spark Therapeutics
Published: 2023-10-26 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

| -10.45% | O: -18.18% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K

| -25.16% | O: 4.02% H: 0.0% C: -4.32%
SRPT | $124.27 6.11% 5.75% 1.3M

| 4.95% | O: 0.27% H: 0.0% C: -4.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -11.44% | O: -15.73% H: 0.0% C: 0.0%
pharma disease companies therapeutics growth market

Oncology Drugs Market to grow at a CAGR of 11.99% from 2022 to 2027. AbbVie Inc., Amgen Inc. & Apikos Pharma are major vendors - Technavio
Published: 2023-07-27 (Crawled : 05:00) - prnewswire.com
ABBNY | News | $48.88 4.05% 190K

| 21.71% | O: 2.13% H: 0.04% C: -1.67%
ABLZF | News | $48.384 -32.74% 3K

Producer Manufacturing

| 18.77% | O: 0.58% H: 0.0% C: -0.46%
GLAXF | News | $19.54 -14.18% 2.6K

| 8.37% | O: 2.38% H: 2.49% C: 2.49%
ALPMY | News | $9.49 -1.11% 480K

| -36.39% | O: 3.75% H: 0.0% C: -2.78%
NVS | News | $98.35 1.1% 0.0% 2.2M

| -4.84% | O: 0.7% H: 0.12% C: -0.76%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 14.97% | O: 1.03% H: 0.39% C: -1.02%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 19.85% | O: 2.13% H: 4.77% C: 3.02%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -11.31% | O: 0.92% H: 0.0% C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 16.3% | O: -0.31% H: 1.71% C: 0.67%
pharma abbvie market

Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 11:00) - prnewswire.com
CSLLY | $90.71 3.3% 35K

| -0.2% | O: -0.54% H: 0.0% C: -1.4%
GLAXF | News | $19.54 -14.18% 2.6K

| 10.71% | O: 0.0% H: 1.42% C: 0.96%
AZNCF | News | $140.3 -4.19% 1.5K

| 5.01% | O: 6.03% H: -2.14% C: -2.14%
ALPMY | News | $9.49 -1.11% 480K

| -34.6% | O: 0.96% H: 0.0% C: -1.71%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 18.51% | O: 0.03% H: 0.2% C: -0.8%
ABT | News | $106.89 -0.65% -0.22% 5.1M

| -0.14% | O: 0.24% H: 0.44% C: -0.06%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -10.4% | O: 0.36% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 4.64% | O: 1.79% H: 0.0% C: -2.23%
pharma vaccine research market

Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026; Astellas Pharma Inc., Athersys Inc., among others, emerge as key vendors - Technavio
Published: 2023-04-12 (Crawled : 14:20) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K

| 20.94% | O: 1.1% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K

| -32.46% | O: 1.92% H: 0.77% C: 0.56%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 3.19% | O: 0.75% H: 0.5% C: -0.05%
BCLI A | $0.5339 1.7% 1.67% 190K

| -81.47% | O: -2.1% H: 0.36% C: -6.07%
pharma cell therapy market

Outlook on the Pharmaceutical Drugs Global Market to 2027: Look at the Changing Structure of the Pharma and Healthcare Industry
Published: 2023-01-03 (Crawled : 13:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

| -94.35% | O: -1.13% H: 28.57% C: 19.0%
CSLLY | $90.71 3.3% 35K

| -7.0% | O: -3.93% H: 2.17% C: 1.75%
MNK | $0.3402 -0.06% 540K

| -94.75% | O: 3.1% H: 0.0% C: -2.75%
GLAXF | News | $19.54 -14.18% 2.6K

| 11.75% | O: -0.2% H: 2.06% C: 2.06%
SNYNF | News | $94.25 -2.18% 480

| -2.1% | O: 1.09% H: 0.54% C: 0.54%
UCBJY | $65.26 -4.38% 5.9K

| 66.06% | O: 1.0% H: 0.0% C: -0.26%
ALPMY | News | $9.49 -1.11% 480K

| -37.4% | O: 3.43% H: 0.0% C: -2.93%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| 2.07% | O: 0.54% H: 2.5% C: 1.7%
NVO | News | $126.16 -1.93% -0.23% 3.1M

| -4.95% | O: 1.43% H: 0.84% C: -0.23%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 8.97% | O: 0.42% H: 1.35% C: 1.22%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

| -15.28% | O: -0.28% H: 1.26% C: 1.15%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| 17.36% | O: -0.57% H: 1.35% C: 1.0%
BHC | $8.56 0.35% 0.0% 2M

| 35.83% | O: 0.48% H: 3.96% C: -0.48%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

| 4.91% | O: 0.27% H: 0.6% C: 0.21%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -2.69% | O: 0.16% H: 0.0% C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

| 4.15% | O: -0.67% H: 0.66% C: 0.3%
pharma global market

ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development
Published: 2022-06-27 (Crawled : 23:00) - biospace.com/
ALPMY | News | $9.49 -1.11% 480K

| -41.44% | O: -1.2% H: 0.0% C: -0.37%
EPIX | $6.38 -0.31% -0.31% 41K

| 60.0% | O: 2.25% H: 0.0% C: -2.69%
epi-7386 pharma therapy update

Interstitial Cystitis Drugs Market - 36% of Growth to Originate from North America| Evolving Opportunities with Astellas Pharma Inc. & Bayer AG | 17000+ Technavio Reports
Published: 2022-06-01 (Crawled : 07:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K

| 27.72% | O: -0.67% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K

| -40.35% | O: 1.7% H: 0.37% C: -0.31%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

| -6.73% | O: 1.23% H: 0.36% C: -2.11%
NVS | News | $98.35 1.1% 0.0% 2.2M

| 9.26% | O: -0.13% H: 0.0% C: 0.0%
pharma growth market

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2022
Published: 2022-05-10 (Crawled : 12:20) - biospace.com/
ALPMY | News | $9.49 -1.11% 480K

| -34.73% | O: 3.06% H: 0.03% C: -0.47%
EPIX | $6.38 -0.31% -0.31% 41K

| 16.36% | O: 3.09% H: 8.47% C: 6.35%
pharma

Vaccines Market Potential to Grow by USD 28.28 billion | Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd. Emerge as Dominant Players | Technavio
Published: 2022-05-02 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

| -10.45% | O: 0.08% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

| 6.02% | O: -1.7% H: 0.0% C: -0.06%
ALPMY | News | $9.49 -1.11% 480K

| -37.44% | O: -1.05% H: 0.2% C: -0.27%
GSK | News | $40.86 -0.92% -0.15% 1.7M

| -9.5% | O: -0.92% H: 0.29% C: -0.95%
SNY | News | $46.66 -2.16% -2.21% 1.7M

| -12.66% | O: -2.05% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

| 6.7% | O: -0.35% H: 0.0% C: 0.0%
pharma biotech potential market

Astellas Pharma Canada Named by the Canadian Society of Transplantation as Member of the Living Donor Circle of Excellence Program
Published: 2021-09-15 (Crawled : 17:00) - biospace.com/
ALPMF | News | $9.5 43.47% 1.2K

| Email alert Add to watchlist
ALPMY | News | $9.49 -1.11% 480K